Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits

Journal of Pediatric Surgery

Volumn 38, Issue 4, 2003, Pages 534-538

  Cheung, P Y ^a   Sawicki, G ^b   Peliowski, A ^b   Etches, P C ^b   Schulz, R ^b   Radomski, M W ^b  

^a ROYAL ALEXANDRA HOSPITAL   (Canada)

^b NONE

Author keywords

Extracorporeal membrane oxygenation; Matrix metalloproteinases; Nitric oxide; Platelet function; Rabbits

Indexed keywords

GELATINASE A; GELATINASE B; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACORPOREAL OXYGENATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RABBIT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

EID: 0037390508     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2003.50116     Document Type: Article

References (22)

1. Robinson TM, Kickler TS, Walker LK, et al: Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 21:1029-1034, 1993
2. Cheung P-Y, Sawicki G, Salas E, et al: The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 28:2584-2590, 2000
3. Neonatal ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, MI, ELSO, January 2002
4. Gait SW, Lindemann S, Allen L, et al: Outside-in signals delivered by MMP-1 regulate platelet function. Circ Res 90:1093-1099, 2002
5. Sawicki G, Salas E, Murat J, et al: Release of gelatinase A during platelet activation mediates aggregation. Nature 386:616-619, 1997
6. Radomski MW, Salas E: Nitric oxide - Biological mediator, modulator and factor of injury: Its role in the pathogenesis of atherosclerosis. Atherosclerosis 118:S69-80, 1995 (Suppl)
7. Anderson HL III, Edmunds LH Jr: Coagulation, anticoagulation and the interaction of blood and artificial surfaces, in Zwischenberger JB, Bartlett RH (eds): ECMO: Extracorporeal life support in critical care. Ann Arbor, MC, ELSO, 1995, pp 53-72
8. Mayers I, Salas E, Hurst T, et al: Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by S-nitrosoglutathione. J Thorac Cardiovasc Surg 117:1009-1016, 1999
9. Mellgren K, Friberg LG, Mellgren G, et al: Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 61:1194-1198, 1996
10. Annich GM, Meinhardt JP, Mowery KA, et al: Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 28:915-920, 2000
11. Cheung P-Y, Salas E, Etches PC, et al: Inhaled nitric oxide and inhibition of platelet aggregation. Lancet 351:1181-1182, 1998
12. Day RW, Lynch JM, White KS, et al: Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 98:698-705, 1996
13. Cottrell ED, Kappa JR, Stenach N, et al: Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 96:535-541, 1988
14. Radomski A, Sawicki G, Olson DM, et al: The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 125:1455-1462, 1998
15. Mellgren K, Mellgren G, Lundin S, et al: Effect of nitric oxide gas on platelets during open heart operations. Ann Thorac Surg. 65:1335-1341, 1998
16. Lowson SM, Hassan HM, Rich GF: The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit. Anesth Analg 89:1360-1365, 1999
17. Roberts JD, Fineman JR, Morin FC, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn, N Engl J Med 336:605-610, 1997
18. Hall MW, Goodman PD, Solen KA, et al: Formation of occlusive platelet aggregates in whole blood caused by low concentrations of ADP. ASAIO J. 46:693-695, 2000
19. Matsunaga T, Weihrauch DW, Moniz MC, et al: Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105:2185-2191, 2002
20. Novaro V, Colman-Lerner A, Ortega FV, et al: Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod Fertil Dev 13:411-420, 2001
21. Nagaya M, Futamura M, Kato J, et al: Application of a new anticoagulant (Nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation - A preliminary report. J Pediatr Surg 32:531-535, 1997
22. Kawai T, Annich GM, Meinhardt JP: Effect of blood flow rate on thrombogenesis in a rabbit extracorporeal circulation model. ASAIO J 45:478-481, 1999